C Technologies, Inc. is excited to announce its acquisition by Repligen Corporation. As a life science company, Repligen Corporation focuses on leading bioprocessing technologies
We understand and support the vital role that our customers fill in the development and manufacture of biological drugs and vaccines. As a company, we are committed to employee health and safety, and to the continued supply of our products and services to our customers globally.
  • • All facilities are operational as we abide by local and national regulations
  • • All products are available with stated lead times
  • • No raw material supply disruptions are anticipated
  • • Commercial and technical support are available remotely, or in person if allowed
Our response on COVID-19 (Coronavirus)
April 6, 2020 Update